Mankind Pharma Makes Stock Market Debut With 20% Premium
The pharmaceutical and consumer health company’s over Rs 4,300 crore initial public offering (IPO) was open for subscription during April 25-27.
May 09, 2023, 15:52 PM IST
Mankind Pharma To Make Stock Market Debut Today; Check What GMP Says
As per reports, the Mankind Pharma latest GMP suggests a premium of Rs 120, suggesting that the scrip will have a remarkable debut on its stock market listing.
May 09, 2023, 09:12 AM IST
Mankind Pharma To Make Stock Market Debut Tomorrow, GMP Indicates Stellar Listing
As per reports, the Mankind Pharma latest GMP suggests a premium of Rs 103, suggesting that the scrip will have a remarkable debut on its stock market listing.
May 08, 2023, 10:09 AM IST
Mankind Pharma IPO Share Allotment: Check Direct Link To See Status, Today's GMP Other Details
Mankind Pharma will start refunds on May 4 if subscribers haven't already got the allotment.
May 03, 2023, 10:42 AM IST
Mankind Pharma IPO: Check GMP, Listing Date And Other Details
Mankind Pharma will finalise the allocation of shares May 3, 2023.
May 02, 2023, 08:45 AM IST
Mankind Pharma IPO Day 3: Check Total Subscription, GMP, Allotment Date, Listing Details And More
On the last day, Mankind Pharama IPO has witnessed so far over 2.25 times over-subscription.
Apr 27, 2023, 12:44 PM IST
Mankind Pharma IPO Day 2: Check Today's GMP, Issue Price, Listing Details And More
Mankind Pharma IPO is entirely an offer for sale (OFS) of 40,058,844 equity shares by promoters and other existing shareholders.
Apr 26, 2023, 07:55 AM IST
Mankind Pharma IPO Opens Next Week: Key Points To Know
The company's IPO is entirely an offer for sale (OFS) of 40,058,844 equity shares by promoters and other existing shareholders.
Apr 19, 2023, 10:16 AM IST
Mankind Pharma files IPO papers with Sebi
The offer for sale comprises of up to 37,05,443 equity shares by Ramesh Juneja, up to 35,05,149 equity shares by Rajeev Juneja, and up to 28,04,119 equity shares by Sheetal Arora (collectively the promoter selling shareholders).
Sep 17, 2022, 09:23 AM IST
Good news! Families of frontline workers to get Rs 100 crore from THIS company
Healthcare workers are working round the clock to save the lives of lakhs of Indians battling Covid-19.
Apr 29, 2021, 10:20 AM IST
Delhi High Court to resume hearing on petitions against Centre's ban on drugs
Delhi High Court is likely to resume today the hearing on petitions by over 30 pharmaceutical majors, including Pfizer, Glenmark, Procter and Gamble (P&G) and Cipla, challenging the government's decision to ban sale of some of their fixed dose combination medicines.
Mar 21, 2016, 07:32 AM IST
Mankind Pharma launches diabetes drug 'Dynaglipt'
Mankind Pharma has launched an anti-diabetic product 'Dynaglipt' targeting the middle class and rural diabetic patients.
Nov 23, 2015, 17:22 PM IST
CCI approves Mankind Pharma's 11% stake sale to PE investors
Approving the deal, the fair trade regulator said the transaction is not likely to have any appreciable adverse effect on competition in India.
Jul 14, 2015, 23:13 PM IST
Mankind Pharma setting up Rs 100 cr facility in Rajasthan
Mankind Pharma is investing around Rs 100 crore to set up an active pharmaceutical ingredients (API) facility in Rajasthan, which is expected to go on stream by the end of the year.
Apr 06, 2015, 18:01 PM IST
